Clinical Trial Update: 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing higher-dose rifampin given for 2 months with standard-dose rifampin for latent tuberculosis infection. The study assesses efficacy and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Latent Tuberculosis | Phase 2 | Status: COMPLETED